dabrafenib mesilate

Spain

Drugs containing this active substance

  • FINLEE 10 MG DISPERSIBLE TABLETS

    It is used in children from 1 year of age to treat a type of brain tumor called glioma (low or high grade), provided the tumor has a specific mutation in the BRAF gene. It is taken in combination with another medication called trametinib.

    Form: tablets, dispersible

    Active substance Dosage
    dabrafenib mesilate 11,85 mg

    ATC: L01E L01EC L01EC02

    Manufacturer: Novartis Europharm Limited

  • It is used in adults to treat a type of skin cancer called melanoma that has spread to other parts of the body or cannot be removed by surgery. It can also be used to prevent melanoma from reappearing after surgery. Additionally, in combination with trametinib, it is used to treat a type of non-small cell lung cancer (NSCLC).

    Form: capsules, hard

    Active substance Dosage
    dabrafenib mesilate 59,25 mg

    ATC: L01E L01EC L01EC02

    Manufacturer: Novartis Europharm Limited

  • It is used in adults to treat a type of skin cancer called melanoma that has spread to other parts of the body or cannot be removed by surgery. It can also be used to prevent melanoma from reappearing after surgery. Additionally, in combination with trametinib, it is used to treat a type of non-small cell lung cancer (NSCLC).

    Form: capsules, hard

    Active substance Dosage
    dabrafenib mesilate 88,88 mg

    ATC: L01E L01EC L01EC02

    Manufacturer: Novartis Europharm Limited